Research and Markets
Renal Cell Carcimona Drug Discoveries - What the Future Holds
Published in Surgery Litigation and Law Weekly, March 19th, 2010
This is a very exciting time in the treatment of renal cell carcinoma (RCC)...
With the advent of the new targeted therapies there has been a complete shift in paradigm. Treatment options for patients with advanced disease have improved dramatically; until recently there was limited choice and therapies were poorly tolerated, with relatively low response rates. Patients now face multiple options with improved safety and efficacy, and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
More Articles from Surgery Litigation and Law Weekly
- American Academy of Dermatology
American Academy of Dermatology Association Disappointed in Failure of Congress to Protect Access to Specialty Care for Medicare Patients - Biomet, Inc.
Biomet Announces National Sponsorship of Arthritis Foundation - Cancer Prevention Institute of California
Rhoads Named Director of Cancer Outreach Programs for Stanford Cancer Center, Cancer Prevention Institute of California - Cross Country Healthcare , Inc.
Cross Country Healthcare Reports Fourth Quarter and Year-End 2009 Results - Life Sciences
Columbia University reports research in life sciences in children - Marler Clark
Salmonella Death in California Leads to Lawsuit Filed by Marler Clark - More from this issue of Surgery Litigation and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
